Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > All news > EMA – Mid-year report 2023
EU-european-medicines-agency-mid-year-report-2023-january-june-2023_18Oct2023-1Download
Ryan McArthur 20 October 2023 All news
  • ← ANSM – Summary of the 2022 Activity Report
  • Benefit-Risk Assessment for New Drug and Biological Products – Guidance for Industry →

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

In partnership with the region

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • Pharmacovigilance Risk Assessment Committee (PRAC) – Minutes of PRAC meeting on 13 – 16 January 2025
  • CTIS newsflash – 25 March 2025
  • 2024 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission
Copyright © 2018 - Pharmya - Legal terms - Quality Policy